AI
UTHR icon

Atria Investments’s United Therapeutics UTHR Stock Holding History

Atria Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$608K Sell
1,122
-10
-0.9% -$5.63K 0.01% 1411
2026
Q1 		$671K Buy
1,132
+2
+0.2% +$996 0.01% 1287
2025
Q4 		$551K Buy
1,130
+93
+9% +$43.3K 0.01% 1385
2025
Q3 		$435K Buy
1,037
+92
+10% +$30.9K 0.01% 1503
2025
Q2 		$272K Buy
945
+106
+13% +$31.7K ﹤0.01% 1767
2025
Q1 		$259K Sell
839
-66
-7% -$22.6K ﹤0.01% 1706
2024
Q4 		$319K Buy
905
+56
+7% +$20.6K ﹤0.01% 1564
2024
Q3 		$304K Sell
849
-350
-29% -$118K ﹤0.01% 1617
2024
Q2 		$382K Buy
+1,199
New +$317K ﹤0.01% 1447

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Atria Investments's UTHR Position: Q2 2026 in Review

Atria Investments reduced its United Therapeutics (UTHR) stake by 0.88% in Q2 2026, selling an estimated $5.63K and leaving 1,122 shares worth $608K. The position accounts for 0.01% of the portfolio, ranked #1411.

Atria Investments first reported a position in UTHR in Q2 2024 and has held it in 9 quarters since. The position peaked at $671K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Atria Investments held 1,122 shares of United Therapeutics worth $608K as of Q2 2026.
  • Atria Investments sold 10 United Therapeutics shares in Q2 2026, an estimated $5.63K.
  • United Therapeutics made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1411 holding.
  • Atria Investments first reported a position in United Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Atria Investments's United Therapeutics position peaked at $671K in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.